McCain urges Trump to make good on promise to address high drug prices

McCain urges Trump to make good on promise to address high drug prices
© Greg Nash

Sens. John McCainJohn Sidney McCainRand Paul’s Russia visit displays advancement of peace through diplomacy GOP leader criticizes Republican senators for not showing up to work CNN poll: Kavanaugh has lowest public support of Supreme Court nominee since Bork MORE (R-Ariz.) and Tammy BaldwinTammy Suzanne BaldwinTrump touts GOP election wins: ‘We have the team we want’ The Hill's Morning Report — GOP seeks to hold Trump’s gains in Midwest states Dems make history in Tuesday's primaries MORE (D-Wis.) on Monday called on President TrumpDonald John TrumpNFL players stand in tunnel during anthem, extending protests 12 former top intel officials blast Trump's move to revoke Brennan's security clearance NYT: Omarosa believed to have as many as 200 tapes MORE to make good on his promise to lower drug prices, writing that the problem "is only getting worse." 

The Trump administration has yet to take substantive action toward reducing the cost of prescription drugs despite promising to do so several times last year and in his State of the Union address last month. 

"We write to urge you to make good on your promise and make fixing the problem of high drug prices a top priority for you and your administration," the senators wrote in a letter to Trump. 

McCain and Baldwin urged the administration to back their bill, which would require drug manufacturers to justify their pricing and provide a breakdown of expenses before increasing the costs of some medicines. 

"This will provide taxpayers, consumers and policymakers with more information, including research and development, marketing and advertising costs," the senators wrote. 

"Drug companies are making lifesaving treatments unaffordable and are forcing families, seniors, taxpayers and our health care system to continue to foot the bill for these price increases with no systematic transparency. It is clear that the market is broken."

The senators wrote that transparency is a "critical first step" in addressing high drug prices. 

"You promised to take on high drug prices as your top priority, so we urge you to call on leadership in Congress to take up and pass our bipartisan legislation," they wrote.